Literature DB >> 21645548

Application of a split luciferase complementation assay for the detection of viral protein-protein interactions.

Qiji Deng1, Dan Wang, Xiaoxiao Xiang, Xiaofei Gao, Philip R Hardwidge, Radhey S Kaushik, Thorsten Wolff, Suvobrata Chakravarty, Feng Li.   

Abstract

Intraviral protein-protein interactions are critical for virus survival in the host. Discovery of such interactions is important to understand molecular mechanisms of viral replication and pathogenesis. The development of a cell-based assay that can be employed to examine systematically viral protein interactions is described. The method, known as the split luciferase complementation assay (SLCA), is based on the principle that N- and C-terminal domains of luciferase alone do not emit luminescence; however, if fused to interacting proteins the two non-functional halves can be brought into close enough proximity through a specific protein-protein interaction to restore the functions of the enzyme and emit detectable light. The well-studied influenza B polymerase acidic protein (PA) and basic protein 1 (PB1) interaction was used as a model system to develop the assay. Consistent with previous studies, a strong PA-PB1 interaction was demonstrated in the assay. The PA-PB1 interaction was also disrupted by single amino acid mutations in the N-terminal domain of PB1 that is responsible for binding PA. The described SLCA is highly specific and easy to perform, and thus may be useful for studying protein-protein interactions in viral diseases.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21645548      PMCID: PMC3479088          DOI: 10.1016/j.jviromet.2011.04.028

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  22 in total

1.  Monitoring protein-protein interactions using split synthetic renilla luciferase protein-fragment-assisted complementation.

Authors:  R Paulmurugan; S S Gambhir
Journal:  Anal Chem       Date:  2003-04-01       Impact factor: 6.986

2.  Noninvasive imaging of protein-protein interactions in living subjects by using reporter protein complementation and reconstitution strategies.

Authors:  R Paulmurugan; Y Umezawa; S S Gambhir
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-18       Impact factor: 11.205

Review 3.  Optimizing luciferase protein fragment complementation for bioluminescent imaging of protein-protein interactions in live cells and animals.

Authors:  Kathryn E Luker; David Piwnica-Worms
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

4.  Molecular imaging of drug-modulated protein-protein interactions in living subjects.

Authors:  Ramasamy Paulmurugan; Tarik F Massoud; Jing Huang; Sanjiv S Gambhir
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

5.  Limited compatibility of polymerase subunit interactions in influenza A and B viruses.

Authors:  Kerstin Wunderlich; Mindaugas Juozapaitis; Benjamin Mänz; Daniel Mayer; Veronika Götz; Andrea Zöhner; Thorsten Wolff; Martin Schwemmle; Arnold Martin
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

6.  Budding of equine infectious anemia virus is insensitive to proteasome inhibitors.

Authors:  Akash Patnaik; Vincent Chau; Feng Li; Ronald C Montelaro; John W Wills
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  Nuclear localization of influenza B polymerase proteins and their binary complexes.

Authors:  Qiji Deng; Dan Wang; Xiaoxiao Xiang; Xiaofei Gao; Philip R Hardwidge; Radhey Kaushik; Thorsten Wolff; Suvobrata Chakravarty; Feng Li
Journal:  Virus Res       Date:  2011-01-05       Impact factor: 3.303

8.  Locating a protein-protein interaction in living cells via split Renilla luciferase complementation.

Authors:  Asami Kaihara; Yasutoshi Kawai; Moritoshi Sato; Takeaki Ozawa; Yoshio Umezawa
Journal:  Anal Chem       Date:  2003-08-15       Impact factor: 6.986

9.  Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.

Authors:  Kerstin Wunderlich; Daniel Mayer; Charlene Ranadheera; Anne-Sophie Holler; Benjamin Mänz; Arnold Martin; Geoffrey Chase; Werner Tegge; Ronald Frank; Ulrich Kessler; Martin Schwemmle
Journal:  PLoS One       Date:  2009-10-20       Impact factor: 3.240

10.  Evolutionarily conserved herpesviral protein interaction networks.

Authors:  Even Fossum; Caroline C Friedel; Seesandra V Rajagopala; Björn Titz; Armin Baiker; Tina Schmidt; Theo Kraus; Thorsten Stellberger; Christiane Rutenberg; Silpa Suthram; Sourav Bandyopadhyay; Dietlind Rose; Albrecht von Brunn; Mareike Uhlmann; Christine Zeretzke; Yu-An Dong; Hélène Boulet; Manfred Koegl; Susanne M Bailer; Ulrich Koszinowski; Trey Ideker; Peter Uetz; Ralf Zimmer; Jürgen Haas
Journal:  PLoS Pathog       Date:  2009-09-04       Impact factor: 6.823

View more
  11 in total

Review 1.  Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system.

Authors:  Bram Stynen; Hélène Tournu; Jan Tavernier; Patrick Van Dijck
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Amino acids essential for the interaction between cellular heat shock protein 90 and a Kaposi's sarcoma-associated herpesvirus-encoded protein kinase ORF36.

Authors:  Chao Wang; Jingchao Wang; Wei Guo; Cong Long; Huan Wang; Xiaoping Sun
Journal:  Virol Sin       Date:  2016-12       Impact factor: 4.327

3.  A split-luciferase complementation, real-time reporting assay enables monitoring of the disease-associated transmembrane protein TREM2 in live cells.

Authors:  Megan M Varnum; Kevin A Clayton; Asuka Yoshii-Kitahara; Grant Yonemoto; Lacin Koro; Seiko Ikezu; Tsuneya Ikezu
Journal:  J Biol Chem       Date:  2017-05-10       Impact factor: 5.157

4.  Development and characterization of an inducible assay system to measure Zika virus capsid interactions.

Authors:  Jieshi Yu; Chen Huang; Zhao Wang; Radhey S Kaushik; Zizhang Sheng; Feng Li; Dan Wang
Journal:  J Med Virol       Date:  2022-07-23       Impact factor: 20.693

5.  Ubiquitination on Lysine 247 of Newcastle Disease Virus Matrix Protein Enhances Viral Replication and Virulence by Driving Nuclear-Cytoplasmic Trafficking.

Authors:  Tingyu Peng; Xusheng Qiu; Lei Tan; Shengqing Yu; Binghuan Yang; Jun Dai; Xiaowen Liu; Yingjie Sun; Cuiping Song; Weiwei Liu; Chunchun Meng; Ying Liao; Weifeng Yuan; Tao Ren; Xiufan Liu; Chan Ding
Journal:  J Virol       Date:  2021-10-27       Impact factor: 6.549

6.  Identification of 4-Anilinoquin(az)oline as a Cell-Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype.

Authors:  Christopher R M Asquith; Louisa Temme; Michael P East; Tuomo Laitinen; Julie Pickett; Frank E Kwarcinski; Parvathi Sinha; Carrow I Wells; Gary L Johnson; Reena Zutshi; David H Drewry
Journal:  ChemMedChem       Date:  2022-05-09       Impact factor: 3.540

7.  Detection of viral protein-protein interaction by microplate-format luminescence-based mammalian interactome mapping (LUMIER).

Authors:  Qiji Deng; Dan Wang; Feng Li
Journal:  Virol Sin       Date:  2014-06       Impact factor: 4.327

Review 8.  New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions.

Authors:  Grant Beyleveld; Kris M White; Juan Ayllon; Megan L Shaw
Journal:  Antiviral Res       Date:  2013-08-06       Impact factor: 5.970

9.  Discovery of Influenza Polymerase PA-PB1 Interaction Inhibitors Using an In Vitro Split-Luciferase Complementation-Based Assay.

Authors:  Jiantao Zhang; Yanmei Hu; Nan Wu; Jun Wang
Journal:  ACS Chem Biol       Date:  2019-11-21       Impact factor: 5.100

10.  A comparative study of short linear motif compositions of the influenza A virus ribonucleoproteins.

Authors:  Chu-Wen Yang
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.